Norian is a subsidiary of Synthes, with global headquarters in Switzerland.
On June 16, 2009, US Attorney Michael L. Levy and Acting Assistant Attorney General Michael F. Hertz announced the return of an indictment against Norian Corporation, Synthes, and four top Synthes executives, Michael D. Huggins (Huggins), Thomas B. Higgins (Higgins), Richard E. Bohner (Bohner) and John J. Walsh (Walsh), charging them for their involvement in conducting clinical trials of a medical device without the authorization of the US Food and Drug Administration (FDA).
